GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Guardian Pharmacy Services Inc (NYSE:GRDN) » Definitions » EV-to-Revenue

GRDN (Guardian Pharmacy Services) EV-to-Revenue : 1.13 (As of May. 23, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Guardian Pharmacy Services EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Guardian Pharmacy Services's enterprise value is $1,451 Mil. Guardian Pharmacy Services's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $1,282 Mil. Therefore, Guardian Pharmacy Services's EV-to-Revenue for today is 1.13.

The historical rank and industry rank for Guardian Pharmacy Services's EV-to-Revenue or its related term are showing as below:

GRDN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.93   Med: 1.13   Max: 1.34
Current: 1.13

During the past 7 years, the highest EV-to-Revenue of Guardian Pharmacy Services was 1.34. The lowest was 0.93. And the median was 1.13.

GRDN's EV-to-Revenue is ranked better than
66.17% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 1.785 vs GRDN: 1.13

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-23), Guardian Pharmacy Services's stock price is $21.94. Guardian Pharmacy Services's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $20.55. Therefore, Guardian Pharmacy Services's PS Ratio for today is 1.07.


Guardian Pharmacy Services EV-to-Revenue Historical Data

The historical data trend for Guardian Pharmacy Services's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardian Pharmacy Services EV-to-Revenue Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial - - - - 1.07

Guardian Pharmacy Services Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.95 1.07 1.07

Competitive Comparison of Guardian Pharmacy Services's EV-to-Revenue

For the Medical Care Facilities subindustry, Guardian Pharmacy Services's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guardian Pharmacy Services's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Guardian Pharmacy Services's EV-to-Revenue falls into.


;
;

Guardian Pharmacy Services EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Guardian Pharmacy Services's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1450.606/1282.307
=1.13

Guardian Pharmacy Services's current Enterprise Value is $1,451 Mil.
Guardian Pharmacy Services's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,282 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guardian Pharmacy Services  (NYSE:GRDN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Guardian Pharmacy Services's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=21.94/20.549
=1.07

Guardian Pharmacy Services's share price for today is $21.94.
Guardian Pharmacy Services's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guardian Pharmacy Services EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Guardian Pharmacy Services's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Guardian Pharmacy Services Business Description

Traded in Other Exchanges
N/A
Address
300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.